-- 
Intercell Finishes Phase II/III Encephalitis Vaccine Study

-- B y   J o n a t h a n   T i r o n e
-- 
2011-09-16T05:45:22Z

-- http://www.bloomberg.com/news/2011-09-16/intercell-finishes-phase-ii-iii-encephalitis-vaccine-study.html
Intercell AG (ICLL) , the Austrian
biotechnology company, said it “successfully” completed its
phase II/III study of a Japanese Encephalitis vaccine for
children.  To contact the editor responsible for this story:
Jonathan Tirone at 
 jtirone@bloomberg.net  